NSE:SUNPHARMA Statistics

Total Valuation

NSE:SUNPHARMA has a market cap or net worth of INR 4.29 trillion. The enterprise value is 4.12 trillion.

Market Cap	4.29T
Enterprise Value	4.12T

Important Dates

The next estimated earnings date is Thursday, May 22, 2025.

Earnings Date	May 22, 2025
Ex-Dividend Date	Feb 6, 2025

Share Statistics

NSE:SUNPHARMA has 2.40 billion shares outstanding. The number of shares has decreased by -0.15% in one year.

Current Share Class	n/a
Shares Outstanding	2.40B
Shares Change (YoY)	-0.15%
Shares Change (QoQ)	+0.24%
Owned by Insiders (%)	12.01%
Owned by Institutions (%)	28.63%
Float	1.04B

Valuation Ratios

The trailing PE ratio is 37.49 and the forward PE ratio is 35.76. NSE:SUNPHARMA's PEG ratio is 2.43.

PE Ratio	37.49
Forward PE	35.76
PS Ratio	8.32
PB Ratio	6.19
P/TBV Ratio	8.43
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	2.43

Financial Ratio History

Enterprise Valuation

EV / Earnings	36.03
EV / Sales	7.98
EV / EBITDA	27.90
EV / EBIT	33.59
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.04
Debt / EBITDA	0.17
Debt / FCF	n/a
Interest Coverage	48.01

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	11.20%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	12.00M
Profits Per Employee	2.66M
Employee Count	43,000
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +16.15% in the last 52 weeks. The beta is 0.55, so NSE:SUNPHARMA's price volatility has been lower than the market average.

Beta (5Y)	0.55
52-Week Price Change	+16.15%
50-Day Moving Average	1,696.22
200-Day Moving Average	1,766.93
Relative Strength Index (RSI)	60.60
Average Volume (20 Days)	2,868,471

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:SUNPHARMA had revenue of INR 516.03 billion and earned 114.34 billion in profits. Earnings per share was 47.71.

Revenue	516.03B
Gross Profit	403.32B
Operating Income	122.81B
Pretax Income	132.97B
Net Income	114.34B
EBITDA	146.44B
EBIT	122.81B
Earnings Per Share (EPS)	47.71

Full Income Statement

Balance Sheet

The company has 201.22 billion in cash and 25.72 billion in debt, giving a net cash position of 175.50 billion or 73.15 per share.

Cash & Cash Equivalents	201.22B
Total Debt	25.72B
Net Cash	175.50B
Net Cash Per Share	73.15
Equity (Book Value)	693.80B
Book Value Per Share	288.72
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 78.16%, with operating and profit margins of 23.80% and 22.16%.

Gross Margin	78.16%
Operating Margin	23.80%
Pretax Margin	25.77%
Profit Margin	22.16%
EBITDA Margin	28.38%
EBIT Margin	23.80%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 15.50, which amounts to a dividend yield of 0.89%.

Dividend Per Share	15.50
Dividend Yield	0.89%
Dividend Growth (YoY)	24.00%
Years of Dividend Growth	6
Payout Ratio	n/a
Buyback Yield	0.15%
Shareholder Yield	1.04%
Earnings Yield	2.66%
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on July 29, 2013. It was a forward split with a ratio of 2.

Last Split Date	Jul 29, 2013
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a